References
- BASF Group. 2008. Technical information – isotretinoin. BASF Group. 2008(03_030772e-08):1–4.
- Cione A, Tonhi E, Silva P. 2011. Stability indicating methods. In: P Shoyama Y, editor. Quality control of herbal medicines and related areas. Rijeka, Croatia: InTech; p. 25–36.
- Dalvi S, Ingale, Hatture PS. 2016. Validated HPLC method for simultaneous estimation of isotretinoin and erythromycin in bulk drug form. Indo Amer J Pharm Res. 6:5254–5259.
- FDA. 2000. FDA guidance for industry, analytical procedures and methods validation: chemistry, manufacturing, and controls documentation, draft guidance. USA: Department of Health and Human Services, Food and Drug Administration.
- Gatti R, Gioia M, Cavrini V. 2000. Analysis and stability study of retinoids in pharmaceuticals by LC with fluorescence detection. J Pharm Biomed Anal. 23:147–159.
- Guimarães C, Mena Mena F, Ivo Lebrun B, Quenca-Guillen I, Auada J, Mercuri A, Ferreira L, Santoro PM. 2010. Determination of isotretinoin in pharmaceutical formulaitons by reversed-phase HPLC. J Biomed Sci Eng. 3:454–458.
- ICH. 2005. ICH Harmonised Tripartite Guideline Validation of Analytucal Procedures: Text and Methodology Q2(R1). International conference of harmonisation of technical requirements for registration of pharmaceuticals for human use.
- IFPMA. 2003. International Conference on Harmonization. Stability Testing of New Drug Substances and Product. Q1A(R2). IFPMA, Geneva, Switzerland.
- Leyden J, Rosso J, Baum E. 2014. The use of isotretinoin in the treatment of acne vulgaris clinical considerations and future directions. Am J Clin Dermatol. 7:4–21.
- Mahajan M, Singh, Jain RS. 2016. Development of a reproducible, sensitive and rapid reversed phase chromatographic method for the estimation of isotretinoin incorporated in bulk drugs, pharmaceutical dosage forms and biological matrix. Cur Pharm Anal. 12:278–285.
- Mukherjee S, Patravale V. 2006. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging. 1:327–348.
- Nováková L, Matysová L, Solish P. 2006a. Advantages of application of UPLC in pharmaceutical analysis. Talanta. 68:908–918.
- Nováková L, L, Matysová P. Solish 2006b. Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. J Sep Sci. 29:2433–2443.
- Pratima B, S. Zibran 2013. Review of ultra performance liquid chromatography and its application. Int J Pharm Sci Res. 23:19–40. 2013.
- Riley C, Rosanske T. 1996. Development and validation of analytical methods. 1st ed. Progress in Pharmaceutical and Biomedical Analysis. Oxford: Elsevier (Pergamon).
- Singh S, M, Junwal G, Modha H, Tiwari M, Kurmi N, Parashar N, Sidduri P. 2013. Forced degradation studies to assess the stability of drugs and products. Trends Anal Chem. 49:71–88.
- Stephen A, Wren C, Tchelitcheff P. 2006. Use of ultra-performance liquid chromatography in pharmaceutical development. J Chromatog A. 1119:140–146.
- Tashtoush B, Jacobson E, Jacobson M. 2007. A rapid HPLC method for simultaneous determination of tretinoin and isotretinoin in dermatological formulations. J Pharmac Biomed Anal. 19:859–864.
- USP 30. 2006. The United States Pharmacopeial Convention.
- Wu T, Wang C, Wang X, Xiao H, Ma O. 2008. Comparison of UPLC and HPLC for analysis of 12 phthalates. Chromatographia. 68:803–806.